National Academy of Inventors Fellows at Purdue: J. Paul Robinson 

May 6, 2026

National Academy of Inventors Fellows at Purdue

Two researchers in white lab coats examine a petri dish near a scientific machine in a lab.

NAI Fellow 2022

J. Paul Robinson

Distinguished Professor of Cytometry and SVM Professor of Cytomics in the College of Veterinary Medicine’s Department of Basic Medical Sciences. Joint appointment as professor of biomedical engineering in the Weldon School of Biomedical Engineering. Director of the Purdue University Cytometry Laboratories.

The NAI Fellows Program celebrates academic inventors whose work spans multiple disciplines and exemplifies their collaboration, dedication and innovation to transform research into real-world commercial technologies that contribute to the betterment of society.

Robinson is renowned for his pioneering contributions to cytomics, spectral flow cytometry, and high-throughput cellular analysis. Robinson’s Purdue team invented spectral flow cytometry, the basis of all current commercial instruments and considered one of the most significant technologies in the field of single-cell biological detection using fluorescence.

Portrait of an elderly man with white hair and beard wearing glasses, a white lab coat, and a patterned bow tie in an office setting

Purdue has a great record of encouragement and entrepreneurship. Support from Purdue Research Park has been a critical component to our success.”
(source)

Robinson has a long career in bringing innovations from lab to life including a 2007 patent licensed to Sony Corp., which successfully commercialized the technology and introduced it into the field. ThermoFisher also licensed the patent related to its spectral sorter released in 2020.

.

0

issued U.S. patents through Purdue

.

0

US/PCT applications

.

0

disclosures

related stories

The story of spectral flow cytometry

BMS Scholar J. Paul Robinson Among Six Purdue Innovators to Receive Trask Innovation Funding

Purdue researchers seeking to repurpose Blu-ray technology to diagnose early-stage cancer receive federal, state grants

Share:

keep exploring